PDGFRA and chronic myelogenous leukemia, BCR-ABL1 positive: Imatinib is an inhibitor of kinases such as the PDGFRA and PDGFRB receptors, currently used to treat some cancers such as chronic myeloid leukemia or gastrointestinal tumors.